March 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apogee Therapeutics, Insmed and Sunoco, on Tuesday.
HIGHLIGHTS
* Apogee Therapeutics Inc APGE.O: Stephens raises target price to $110 from $100 |
* Ecolab Inc ECL.N: JP Morgan raises to overweight from neutral |
* Insmed Inc INSM.O: Leerink Partners raises target price to $215 from $210 |
* Ligand Pharmaceuticals Inc LGND.O: Citigroup raises target price to $276 from $270 |
* Sunoco LP SUN.N: JP Morgan raises target price to $73 from $66 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aardvark Therapeutics Inc AARD.O: B. Riley cuts target price to $8 from $32 |
* ADM ADM.N: JP Morgan raises target price to $65 from $61 |
* Alaska Air Group Inc ALK.N: BMO initiates with outperform rating; target price $50 |
* Antero Resources Corp AR.N: Truist Securities initiates with buy rating; target $56 |
* APA Corporation APA.O: Barclays raises target price to $35 from $28 |
* APA Corporation APA.O: Barclays raises to equal weight from underweight |
* APA Corporation APA.O: Truist Securities initiates with hold rating; target price $38 |
* Apogee Therapeutics Inc APGE.O: Citigroup raises target price to $125 from $95 |
* Apogee Therapeutics Inc APGE.O: Stephens raises target price to $110 from $100 |
* Apogee Therapeutics Inc APGE.O: Deutsche Bank raises target price to $118 from $108 |
* Apollo APO.N: BMO cuts target price to $116 from $135 |
* Apple Hospitality Reit, Inc. APLE.N: Wells Fargo cuts target price to $12 from $13 |
* Ares Management Corp ARES.N: BMO cuts target price to $112 from $140 |
* Arthur J. Gallagher & Co AJG.N: BMO raises target price to $278 from $275 |
* Arthur J. Gallagher & Co AJG.N: BMO raises to outperform from market perform |
* AT&T Inc T.N: Moffettnathanson raises target price to $27 from $22 |
* BKV Corp BKV.N: Truist Securities initiates coverage with buy rating; target $37 |
* Blackstone BX.N: BMO cuts target price to $126 from $165 |
* Brixmor Property Group Inc BRX.N: Scotiabank raises target price to $33 from $29 |
* Bunge BG.N: JP Morgan raises target price to $134 from $130 |
* Carlyle Group Inc CG.O: BMO cuts target price to $58 from $65 |
* Carnival Corp CCL.N: Barclays cuts target price to $36 from $37 |
* CF Industries Holdings CF.N: HSBC raises target price to $130 from $91 |
* Chord Energy Corp CHRD.O: Truist Securities initiates with buy rating; target $169 |
* CNX Resources Corp CNX.N: Truist Securities initiates with sell rating; target $35 |
* Conocophillips COP.N: Truist Securities initiates with hold rating; target price $124 |
* Core Natural Resources Inc CNR.N: UBS raises target price to $115 from $109 |
* Corecivic Inc CXW.N: Benchmark initiates coverage with buy rating; target price $28 |
* Coreweave Inc CRWV.O: BofA Global Research reinstates with buy rating; PT $100 |
* Covista Inc CVSA.N: Truist Securities initiates coverage with buy rating; target $130 |
* Darling Ingredients Inc DAR.N: JP Morgan raises target price to $69 from $59 |
* Delek Logistics Partners LP DKL.N: Truist Securities initiates with hold rating; PT $57 |
* Delek US Holdings DK.N: BofA Global Research raises price objective to $40 from $28 |
* Devon Energy Corp DVN.N: Truist Securities initiates coverage with buy rating; PT $63 |
* Dexcom Inc DXCM.O: Evercore ISI raises target price to $90 from $68 |
* Dexcom Inc DXCM.O: Evercore ISI raises to outperform from in line |
* Diamondback Energy FANG.O: Truist Securities initiates with buy rating; target $222 |
* Ecolab Inc ECL.N: JP Morgan raises to overweight from neutral |
* Energy Transfer LP ET.N: Truist Securities initiates coverage with buy rating; PT $23 |
* Enterprise Products Partners L.P EPD.N: Truist Securities initiates with hold rating; PT $36 |
* Expand Energy EXE.O: Truist Securities initiates coverage with buy rating; target $136 |
* Federal Realty Investment Trust FRT.N: Scotiabank raises target to $118 from $113 |
* FTAI Aviation Ltd FTAI.O: Morgan Stanley raises target price to $293 from $266 |
* Generate Biomedicines GENB.O: Piper Sandler initiates with overweight rating; PT $24 |
* Generate Biomedicines GENB.O: Morgan Stanley initiates with overweight rating; PT $20 |
* Gulfport Energy GPOR.N: Truist Securities initiates coverage with hold rating; PT $230 |
* Hallador Energy Co HNRG.O: Jefferies initiates with hold rating; price target $17.5 |
* Hamilton Lane Inc HLNE.O: BMO cuts target price to $118 from $148 |
* Host Hotels & Resorts, Inc. HST.O: Wells Fargo raises target price to $20 from $19 |
* Insmed Inc INSM.O: Leerink Partners raises target price to $215 from $210 |
* Insmed Incorporated INSM.O: Wells Fargo raises target price to $177 from $175 |
* JetBlue Airways JBLU.O: BMO initiates coverage with market perform rating; target $4.5 |
* Jfrog Ltd FROG.O: UBS raises to buy from neutral |
* Kinder Morgan Inc KMI.N: Jefferies raises target price to $36 from $31 |
* Kinder Morgan Inc KMI.N: Truist Securities initiates with hold rating; target $38 |
* Kinetik Holdings Inc KNTK.N: Truist Securities initiates with buy rating; target $53 |
* KKR KKR.N: BMO cuts target price to $106 from $125 |
* Krystal Biotech KRYS.O: BofA Global Research raises price objective to $325 from $318 |
* Kyndryl Holdings Inc KD.N: Morgan Stanley cuts target price to $13 from $28 |
* Lamb Weston Holdings Inc LW.N: JP Morgan cuts target price to $44 from $50 |
* Lci Industries LCII.N: Stifel initiates coverage with buy rating; price target $152 |
* Ligand Pharmaceuticals Inc LGND.O: Citigroup raises target price to $276 from $270 |
* Mach Natural Resources LP MNR.N: Truist Securities initiates with hold rating; PT $14 |
* Magnolia Oil & Gas MGY.N: Truist Securities initiates with hold rating; target $33 |
* Marathon Petroleum MPC.N: BofA Global Research raises price objective to $247 from $201 |
* Matador Resources Co MTDR.N: Truist Securities initiates with hold rating; target $60 |
* McCormick & Company Inc MKC.N: Bernstein cuts target price to $77 from $85 |
* Microsoft MSFT.O: BofA Global Research reinstates with buy rating; PT $500 |
* MPLX LP MPLX.N: Truist Securities initiates coverage with buy rating; PT $67 |
* Ncino Inc NCNO.O: Barclays cuts target price to $21 from $34 |
* Nektar Therapeutics NKTR.O: Wedbush initiates coverage with neutral rating; PT $70 |
* New York Times Co NYT.N: Citigroup raises target price to $94 from $77 |
* Occidental Petroleum Corp OXY.N: Truist Securities initiates coverage with hold rating; target price $65 |
* Ondas Inc ONDS.O: Needham raises target price to $23 from $17 |
* ONEOK Inc OKE.N: Truist Securities initiates coverage with hold rating; target $91 |
* Oracle Corp ORCL.N: BofA Global Research reinstates with buy rating; PT $200 |
* Ovintiv Inc OVV.N: Truist Securities initiates coverage with buy rating; target $70 |
* Palvella Therapeutics Inc PVLA.O: H.C. Wainwright raises PT to $270 from $255 |
* Park Hotels & Resorts Inc PK.N: Wells Fargo cuts target price to $10 from $11 |
* PBF Energy Inc PBF.N: BofA Global Research raises price objective to $35 from $25 |
* Pebblebrook Hotel Trust PEB.N: Wells Fargo cuts target price to $12 from $13 |
* Permian Resources Holdings Inc PR.N: Raymond James raises target price to $29 from $21 |
* Permian Resources Holdings Inc PR.N: Truist Securities initiates coverage with buy rating; target price $24 |
* Pfizer PFE.N: Guggenheim raises target price to $36 from $35 |
* Phillips 66 PSX.N: BofA Global Research raises price objective to $183 from $154 |
* Phreesia Inc PHR.N: Mizuho cuts target price to $19 from $22 |
* Plains All American Pipeline PAA.O: Truist Securities initiates coverage with buy rating; target price $23 |
* Plains GP Holdings LP PAGP.O: Truist Securities initiates with buy rating; target $23 |
* Profrac Holding Corp ACDC.O: Morgan Stanley raises target price to $5 from $4 |
* Ralph Lauren Corp RL.N: Citigroup raises target price to $400 from $360 |
* Ralph Lauren Corp RL.N: Citigroup raises to buy from neutral |
* Range Resources Corp RRC.N: Truist Securities initiates with hold rating; target $48 |
* Regency Centers Corp REG.O: Scotiabank raises target price to $82 from $76 |
* Relmada Therapeutics RLMD.O: Piper Sandler initiates with overweight rating; PT $12 |
* Riley Exploration Permian REPX.A: Truist Securities initiates with buy rating; PT $47 |
* Ryman Hospitality Properties RHP.N: Wells Fargo cuts target price to $105 from $109 |
* Simon Property Group Inc SPG.N: Scotiabank raises target price to $192 from $189 |
* SM Energy Co SM.N: Truist Securities initiates coverage with buy rating; target $38 |
* Stepstone Group Inc STEP.O: BMO cuts target price to $58 from $70 |
* Sunoco LP SUN.N: JP Morgan raises target price to $73 from $66 |
* Sunstone Hotel Investors, Inc. SHO.N: Wells Fargo cuts target price to $10 from $11 |
* Super Micro Computer SMCI.O: BofA Global Research cuts PT to $24 from $34 |
* Super Micro Computer Inc SMCI.O: Citigroup cuts target price to $25 from $39 |
* Surrozen Inc SRZN.O: H.C. Wainwright raises target price to $36 from $32 |
* Sutro Biopharma Inc STRO.O: H.C. Wainwright raises target price to $28 from $10 |
* Sutro Biopharma Inc STRO.O: Piper Sandler raises target price to $29 from $20 |
* Sutro Biopharma Inc. STRO.O: Wells Fargo raises target price to $27 from $8 |
* Sutro Biopharma Inc. STRO.O: Wells Fargo raises to overweight from equal weight |
* Targa Resources Corp TRGP.N: Truist Securities initiates with buy rating; target $279 |
* Targa Resources Corp TRGP.N: UBS raises target price to $280 from $228 |
* the Estee Lauder Companies Inc. EL.N: Wells Fargo cuts target price to $90 from $105 |
* TPG Inc TPG.O: BMO cuts target price to $48 from $60 |
* Tyson Foods Inc TSN.N: JP Morgan cuts target price to $65 from $67 |
* Valero Energy VLO.N: BofA Global Research raises price objective to $247 from $195 |
* Verizon VZ.N: MoffettNathanson raises target price to $56 from $49 |
* Viatris Inc VTRS.O: Barclays raises target price to $17 from $15 |
* WEC Energy Group Inc WEC.N: Barclays raises target price to $111 from $110 |
* Williams Companies WMB.N: Truist Securities initiates with buy rating; target $84 |
* Xencor Inc XNCR.O: JP Morgan cuts target price to $13 from $18 |
* Xencor Inc XNCR.O: JP Morgan cuts to neutral from overweight |
* Xilio Therapeutics XLO.O: Leerink Partners adjusts PT to $20 from $2 to reflect 1-for-14 reverse stock split |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))